MRD detection of leukemia relapse using HLA typing by FACS in combination with FISH after mismatched allogeneic stem cell transplantation

Pediatric Transplantation

Volumn 18, Issue 5, 2014, Pages

  Miyachi, Mitsuru ^a   Watanabe, Eri ^b   Watanabe, Nobukazu ^b   Tsuma, Yusuke ^a   Kawashima Goto, Sachiko ^a   Tamura, Shinichi ^c   Imamura, Toshihiko ^a,d   Ishida, Hiroyuki ^a,c   Hosoi, Hajime ^a  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c MATSUSHITA MEMORIAL HOSPITAL   (Japan)

^d KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

Author keywords

HLA Flow; minimal residual disease; mismatched allo SCT; mismatched HLA allele

Indexed keywords

CORTICOSTEROID; HLA A24 ANTIGEN; HLA DRB1 ANTIGEN; MELPHALAN; METHOTREXATE; METHYLPREDNISOLONE; TACROLIMUS; THYMOCYTE ANTIBODY; HLA ANTIGEN;

ALLELE; ALLOGENEIC STEM CELL TRANSPLANTATION; ARTICLE; CASE REPORT; CHILD; CORTICOSTEROID THERAPY; FEMALE; FLUORESCENCE ACTIVATED CELL SORTING; FLUORESCENCE IN SITU HYBRIDIZATION; GENE DOSAGE; GRAFT VERSUS HOST REACTION; HLA TYPING; HUMAN; INDUCTION CHEMOTHERAPY; LEUKEMIA CELL; LEUKEMIA RELAPSE; LEUKEMIA REMISSION; MALE; MINIMAL RESIDUAL DISEASE; MYELOABLATIVE CONDITIONING; PRESCHOOL CHILD; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCHOOL CHILD; ALLOTRANSPLANTATION; CELL SEPARATION; FLOW CYTOMETRY; GENETICS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HISTOCOMPATIBILITY TEST; IMMUNOLOGY; LEUKEMIA, MYELOID, ACUTE; NEOPLASM, RESIDUAL; TREATMENT OUTCOME; TUMOR RECURRENCE;

ALLELES; CELL SEPARATION; CHILD; FEMALE; FLOW CYTOMETRY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HISTOCOMPATIBILITY TESTING; HLA ANTIGENS; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; LEUKEMIA, MYELOID, ACUTE; MALE; NEOPLASM RECURRENCE, LOCAL; NEOPLASM, RESIDUAL; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME;

EID: 84904013407     PISSN: 13973142     EISSN: 13993046     Source Type: Journal    
DOI: 10.1111/petr.12267     Document Type: Article

References (8)

1. Fuchs EJ, Huang XJ, Miller JS,. HLA-haploidentical stem cell transplantation for hematological malignancies. Biol Blood Marrow Transplant 2010: 16: 57-63.
2. Wang Y, Liu DH, Xu LP, et al. Superior graft-versus leukemia effect associated with transplantation of haploidentical compared with HLA-identical sibling donor grafts for high risk acute leukemia: An historic comparison. Biol Blood Marrow Transplant 2011: 17: 821-830.
3. Lee KH, Lee JH, Lee JH, et al. Reduced intensity conditioning therapy with busulfan, fludarabine, and antithymocyte globulin for HLA-haploidentical hematopoietic transplantation in acute leukemia and myelodysplastic syndrome. Blood 2011: 118: 2609-2617.
4. Vago L, Perna SK, Zanussi M, et al. Loss of mismatched HLA in leukemia after stem-cell transplantation. N Engl J Med 2009: 361: 478-488.
5. Tamaki H, Fujioka T, Ikegame K, et al. Different mechanisms causing loss of mismatched human leukocyte antigens in relapsing t(6;11)(q27;q23) acute myeloid leukemia after haploidentical transplantation. Eur J Haematol 2012: 89: 497-500.
6. Villalobos IB, Takahashi Y, Akatsuka Y, et al. Relapse of leukemia with loss of mismatched HLA resulting from uniparental disomy after haploidentical hematopoietic stem cell transplantation. Blood 2010: 115: 3158-3161.
7. Waterhouse M, Pfeifer D, Pantic M, Emmerich F, Bertz H, Finke J,. Genome-wide profiling in AML patients relapsing after allogeneic hematopoietic cell transplantation. Biol Blood Marrow Transplant 2011: 17: 1450-1459.
8. Watanabe N, Takahashi S, Ishige M, et al. Recipient-derived cells after cord blood transplantation: Dynamics elucidated by multicolor FACS, reflecting graft failure and relapse. Biol Blood Marrow Transplant 2008: 14: 693-701.